Although the post-translational modifications of caveolin-3 have received limited attention, there is evidence to suggest that mutations in the CAV3 gene, which result in muscular dystrophy, are broken down through ubiquitination and proteasomal pathways. The gene discussed is CAV3; the disease is muscular dystrophy.